DR PRAVEEN K TRIPATHI
02-Dec-15 1
 In 1964, Colombian
neurosurgeon Salomón
Hakim and colleagues
described a syndrome of
Progressive cognitive
decline
Gait difficulties
Urinary incontinence
Ventricular dilatation
Normal cerebrospinal
fluid (CSF) pressure
during lumbar puncture
02-Dec-15 2
1982, CM Fisher underscored the importance of
the gait disturbance in the description of NPH.
1986, Graff-Radford and Godersky correlated
clinical symptoms and shunt responsiveness.
The term idiopathic adult hydrocephalus
syndrome may be more accurate, because
intracranial pressure is not always normal in
NPH.
02-Dec-15 3
 elderly individuals (age >65 y) the prevalence of
NPH was 1.4%
 Incidence -1.4 per 1,00,000
 No race or gender prediliction
 more than 60% of patients with iNPH had
cerebrovascular disease.
 In another similar study, more than 75% had
Alzheimer disease pathology at the time of shunt
surgery.
02-Dec-15 4
IDIOPATHIC – 50 %
SECONDARY CAUSES
 subarachnoid hemorrhage (23%),
 meningitis (4.5%)
 and traumatic brain injury (12.5%)
Secondary NPH has higher response rate to
shunting than idiopathic NPH
02-Dec-15 5
 50% cases idiopathic
 Leading theory is impairment of CSF outflow
 Intraventricular pressure studies reveal waves
of increased pressure- B-waves
 Adult hydrocephalus syndrome
 Adult symptomatic hydrocephalus
02-Dec-15 6
02-Dec-15 7
Ventricle enlargement leads to periventricular
ischemia regardless of etiology
Compression and stretching of arterioles and
venules
Arterial hypertension and cerebral
arteriosclerosis increased in NPH
02-Dec-15 8
Increased subarachnoid space volume does not
accompany increased ventricular volume.
Symptoms result from distortion of the central
portion of the corona radiata by the distended
ventricles. Interstitial edema of the white matter
The periventricular white matter anatomically
includes the sacral motor -abnormal gait and
incontinence.
Dementia results from distortion of the
periventricular limbic system.02-Dec-15 9
Kiefer, M; Unterberg, A
The Differential Diagnosis and Treatment of Normal-Pressure Hydrocephalus
Dtsch Arztebl Int 2012; 109(1-2): 15-26; DOI: 10.3238/arztebl.2012.0015
02-Dec-15 10
CLASSIC TRIAD
 GAIT DISTURBANCE -is typically the earliest feature
noted and considered to be the most responsive to treatment
 No classic gait disturbance
 Gait may be wide based, shuffling
 More severely affected patients have “magnetic gait”- feet
stuck to ground and difficult to initiate walking
 Difficulties with walking motions resolve with minimal
support of patient or lying patient down
 May resemble Parkinson’s gait
 Hyperreflexia
 Apraxia of gait – no weakness or ataxia.
02-Dec-15 11
02-Dec-15 12
Urinary Incontinence
 True incontinence found only in severely
affected patients
 Urinary urgency in most patients with NPH
 Due to stretching of periventricular nerve
fibers and loss of detrusor inhibition
 Bladder sphincter muscle unaffected
02-Dec-15 13
DEMENTIA
 Usually mild
 Presence of dementia in NPH extremely variable
 Some shunt responsive patients have little or no
dementia
 Dementia usually least responsive of symptoms to
intervention
 Mental status changes may resemble depression
 prominent memory loss and bradyphrenia.
 Frontal and subcortical deficits
 forgetfulness, decreased attention,
 Aphasia /agnosia – alternate diagnosis -Alzheimer
02-Dec-15 14
 Both AD and NPH cause memory impairment
 AD- “cortical” abnormalities
 Aphasia, Apraxia, Agnosia
 Impaired recognition and encoding deficits
 NPH- “subcortical” abnormalities
 Memory impairment but intact recognition
 Slow information processing
 Difficulty with complex tasks
02-Dec-15 15
AD NPH
Impaired
Memory
Learning
Orientation
Attention/concentration
Executive function
Writing
Psychomotor slowing
Fine motor speed
Fine motor accuracy
Borderline
Impaired
Motor and psychomotor skills
Visuospatial skills
Language
Reading
Auditory memory
Attention/concentration
Executive function
Behavior/personality
changes
02-Dec-15 16
 AD and NPH can usually be distinguished with
formal neuropsychological testing
 Primary care office testing may not be
adequate to distinguish
 Mental impairment early in course of AD but
usually late in course of NPH and often
minimal impairment
 AD often associated with hippocampal atrophy
on imaging studies
02-Dec-15 17
 Both NPH and Parkinson’s Disease (PD) can
have similar gait disturbances
 Hypokinesia
 Freezing
 Imbalance
 Extrapyramidal symptoms
 Trial of levadopa can help distinguish between
PD and NPH
02-Dec-15 18
 Depression
 Subcortical arteriosclerotic encephalopathy
 Multi-infarct encephalopathy
 Chronic alcoholism
 B12, Folate deficiency
 Electrolyte abnormalities
 Cervical or lumbar stenosis
 Peripheral neuropathy
02-Dec-15 19
 History
 Insidious onset
 Age over 40
 Symptom duration 3-6 months
 No antecedent event known to cause
secondary NPH
 Progressive over time
 No other medical, psychiatric or neurological
condition that could cause symptoms
02-Dec-15 20
 Brain imaging
 Ventricular enlargement not attributable to
cerebral atrophy or congenital disorder
 No macroscopic obstruction present
 At least one of the following
 Enlargement of lateral horns not attributable to
hippocampus atrophy
 Callosal angle greater or equal to 40 degrees
 Evidence of altered brain water content on
imaging not attributable ischemia or
demylination
 An aqueductal or fourth ventricular flow void on
MRI 02-Dec-15 21
02-Dec-15 22
 Angle of roof of lateral ventricles in A-P projection
02-Dec-15 23
 Loss of MRI signal due to flow of CSF
Normal aqueduct Abnormal aqueduct
02-Dec-15 24
Normal fourth ventricle Abnormal fourth ventricle
02-Dec-15 25
 Clinical
 Gait/Balance- at least two of following present
 Decreased step height
 Decreased step length
 Decreased cadence/speed
 Decreased trunk sway
 Widened stance
 Toes turned outward while walking
 En bloc turning- turns take three or more steps
 Impaired balance- two or more corrective steps
for eight steps on tandem gait testing
02-Dec-15 26
 Cognition- two of following present
 Psychomotor slowing
 Decreased fine motor speed
 Decreased fine motor accuracy
 Difficulty dividing or maintaining attention
 Impaired recall especially for recent events
 Impairment of executive functions- multi-step
procedures, working memory, formulation of
abstractions, insight
 Behavioral or personality changes
02-Dec-15 27
 Urinary Symptoms- one of following
 Episodic urinary incontinence not attributable
to other causes
 Persistent urinary incontinence
 Fecal and urinary incontinence
OR
 One of following
 Urinary urgency
 Urinary frequency- 6 or more voids in 12 hour
period
 Nocturia- more than two voids in night
02-Dec-15 28
 Physiological
 Opening pressure 70-240 mmH2O
02-Dec-15 29
 History- Symptoms are
 Subacute or indeterminate onset
 Onset any time after childhood
 <3 months or indeterminate duration
 May follow trauma, hemorrhage or meningitis
 Symptoms not entirely explained by co-existing
neurological conditions
 Non-progressive or not clearly progressive
02-Dec-15 30
 Brain imaging- Ventricular enlargement
associated with following
 Cerebral atrophy of sufficient severity to
explain ventricular enlargement
 Structural lesion that may increase
ventricular size
02-Dec-15 31
 Clinical
 Incontinence and/or cognitive impairment in
absence of gait or balance dysfunction
 Gait disturbance or dementia alone
 Physiological
 Opening pressure unavailable or outside of
range for probable NPH
02-Dec-15 32
No ventriculomegaly
Signs of increased intracranial pressure
such as papilledema
No component of clinical triad
Symptoms explained by other causes (eg,
spinal stenosis)
02-Dec-15 33
- Vit B12 , Thyroid profile
- CSF – analysis –
opening pressure – 11 +/- 3 mm hg (150 mm H2o)
slightly higher than normal
- Transient high pressure B waves may be detected
- (CSF) protein Lipocalin-type prostaglandin D
synthase (L-PGDS) – marker of Frontal lobe
dysfunction in iNPH – decreased due to damage
of arachnoid cells
02-Dec-15 34
 Ventriculomegaly that is out of proportion to sulcal
atrophy.
 differentiates NPH from ex vacuo
ventriculomegaly,
 Frontal and occipital periventricular
hypoattenuating areas, represent transependymal
CSF flow -infrequent and often may represent
periventricular leukoencephalopathy
 corpus callosal thinning, -nonspecific
02-Dec-15 35
 Rounding of frontal horns
 clinical picture and ventriculosulcal
disproportion on either CT or MRI
scans, 50-70% of patients are likely to
respond to a CSF-shunting procedure.
02-Dec-15 36
disproportionately enlarged temporal
horns of the lateral ventricles compared
with the relatively normal sulcal size.
02-Dec-15 37
The Evans index (EI), a linear ratio
between the maximal frontal horn width
and the cranium diameter,
signifies ventriculomegaly if it is 0.3
02-Dec-15 38
 Temporal horns out of proportion to hippocampal
atrophy
 MRI provides additional physiologic information on
NPH
 T2-weighted images, regions of moving CSF
demonstrate no signal, instead of the increased
signal observed in slow-moving CSF,
 CSF flow studies- jet of turbulent CSF flow may be
observed distal to the aqueduct
 Cine phase-contrast MRI quantifies CSF flow in
terms of stroke volume
 - significant corelation to shunt responsiveness02-Dec-15 39
02-Dec-15 40
 Most prefer 45 -50 ml removal
 Csf pressures may be transiently elevated
 Improvement may be delayed and appear 1-2
days after
 Sensitivity of test – 62 % and 33 % specificity
 However it has been listed in guidelines of
prognostic evaluation of NPH
02-Dec-15 41
 greater impact on brain volume expansion
 300 ml drained for 5 days
 Complications -including headache,
radiculopathy, and bacterial meningitis
 More sensitive than csf tap test
 sensitivity, specificity, and negative predictive
value were 95%, 64%, and 78%, respectively.
 PPV 80 -100 %
 Requires hospitalisation specialised care
02-Dec-15 42
02-Dec-15 43
 CSF infusion testing.- One drain is used for
continuous pressure monitoring while the other drain
is used to continuously infuse solution into the CSF
space.
 Ro – impedance of flow offered by csf absorption
 Isotopic cisternography is no longer in frequent use
 Acqueductal CSF flow – not of much diagnostic use
02-Dec-15 44
02-Dec-15 45
 Neuropsychological evaluation (eg, Folstein test
or formal neuropsychological evaluation)- not
validated
 Timed walking test.
 Videotaping the gait evaluation before and after
the large volume lumbar puncture.- IS
PREFERABLE
 Reduction in bladder hyperactivity also may be a
sign of good outcome from shunting.
02-Dec-15 46
 No prospective, double blind, randomized, controlled
clinical triaL
 Medical management – levodopa trial to rule out
idiopthic parkinson disease
 No drug is known to work in NPH
 Surgical Management – mainstay
 Benefit expected from shunt surgery in probable case
of NPH 50 %- 61 %
02-Dec-15 47
02-Dec-15 48
02-Dec-15 49
02-Dec-15 50
 Adjustable shunt valves – adjusts the opening
pressure
 Gravity-controlled valves - low valve opening
pressure when the patient is lying down.
 G valves lower the risk of overdrainage by 90%
02-Dec-15 51
 Endoscopic third ventriculostomy (ETV).
 Alternative to shunt placement for treatment
of hydrocephalus.
 Effective in obstructive hydrocephalus.
Efficacy in NPH not known
02-Dec-15 52
 Routine follow up 2 to 3 times per year
 Earlier if shunt inection/failure
 Bedside clinical examination follow up CTScan
within few weeks
 D Dimer ,CRP in case of ventriculoatrial shunts
for subclinical septicemia and
thromboembolism
02-Dec-15 53
 High CSF pressure should prompt investigation
for a secondary cause of NPH
 Response to a 40-mL to 50-mL (high-volume)
lumbar tap suggests a potential benefit to shunting
 An ELD may be used to evaluate those who do
not respond to a high-volume tap
 There is no substantial predictive value to MRI
CSF flow studies
 IF multi-infarct or Alzheimer’s disease
dementia ??
02-Dec-15 54
 Ventricle enlargement on CT or MRI
 Severity graded by ratio of maximal frontal horn
width divided by transverse inner diameter of
skull
 0.32 minimal for NPH but 0.40 more typical
 Lack of hippocampus or cortical atrophy
 Periventricular and cortical white matter lesions
may be found in patients with NPH
 Large number white matter lesions may be marker
for poor response to shunting
02-Dec-15 55
02-Dec-15 56
Enlarged
Ventricles
02-Dec-15 57
Enlarged
Ventricles
02-Dec-15 58
 Most studies show fairly significant decline in
benefits over time
 Initial improvement 60-75% of patients
 Sustained improvement only 24-42%
 Results confounded due to high mortality
from co-morbid conditions
 57% patients dead within 5 years in study by
Raftopoulos et.al.
02-Dec-15 59
 Good response to shunting
 Clinical presentation
 Gait disturbance preceded mental impairment
 Short duration of mild mental impairment
 Known cause of NPH- e.g. infection, bleed
02-Dec-15 60
 Good response to shunting
 Special studies
 Lack of white matter lesions on MRI
 Marked resolution of symptoms with CSF
drainage
 One time removal 30-50 cc CSF
 Multi-day drainage of 100-150 cc CSF
 B-waves greater than 50% of time with
continuous intracranial pressure (ICP)
monitoring
 Resistance to CSF outflow greater than 18
mmHg 02-Dec-15 61
 Poor response to shunting
 Severe dementia
 Dementia presenting symptom
 MRI abnormalities
 Cerebral atrophy
 Multiple white matter lesions
02-Dec-15 62
 Indeterminate significance
 Patient age
 Duration of symptoms
 Lack of response to removal CSF
02-Dec-15 63
Normal pressure hydrocephalus: an update, Stein, SC, Neurosurgery
Quarterly (2001)11(1):26–35
02-Dec-15 64
Normal pressure hydrocephalus: an update, Stein, SC, Neurosurgery
Quarterly (2001)11(1):26–35
02-Dec-15 65
 Externally programmable valve allows
transcutaneous adjustment CSF outflow resistance
02-Dec-15 66
02-Dec-15 67
 Monitoring of mental function
 Patients should have neuropsychiatric testing
prior to shunt
 Periodic testing post shunt to document
improvement
02-Dec-15 68
 Monitor for complications of shunt
 Infection
 Shunt malfunction
 Excessive CSF drainage
 Subdural hematoma
02-Dec-15 69
02-Dec-15 70
 The INPH is a syndrome, characterized by gait
impairment, cognitive decline and urinary
incontinence
 Associated with ventriculomegaly in the absence of
elevated CSF pressure.
 Pathogenesis is not understood; intermittent
intracranial hypertension, decreased CSF
absorption and cerebral ischemia have been
blamed.
 Hallmark of neuroimaging in NPH is
ventriculomegaly out of proportion with sulcal
atrophy 02-Dec-15 71
 MRI is the choice of imaging; CSF flow in NPH is
hyperdynamic, with an increase in the amount and
velocity of CSF passing rostrally, then caudally, through
the cerebral aqueduct with each cardiac cycle.
 Clinical improvement after CSF drainage implies good
response to shunting.·
 The best results are found in the subjects treated with
low-pressure valves.·
 Increased use of adjustable valve seems to be beneficial.
 Gait is most likely to improve. Postoperative reduction
in ventriculomegaly is not always seen or proportionate
to the clinical improvement.
02-Dec-15 72
THANK YOU
02-Dec-15 73

Normal pressure hydrocephalus

  • 1.
    DR PRAVEEN KTRIPATHI 02-Dec-15 1
  • 2.
     In 1964,Colombian neurosurgeon Salomón Hakim and colleagues described a syndrome of Progressive cognitive decline Gait difficulties Urinary incontinence Ventricular dilatation Normal cerebrospinal fluid (CSF) pressure during lumbar puncture 02-Dec-15 2
  • 3.
    1982, CM Fisherunderscored the importance of the gait disturbance in the description of NPH. 1986, Graff-Radford and Godersky correlated clinical symptoms and shunt responsiveness. The term idiopathic adult hydrocephalus syndrome may be more accurate, because intracranial pressure is not always normal in NPH. 02-Dec-15 3
  • 4.
     elderly individuals(age >65 y) the prevalence of NPH was 1.4%  Incidence -1.4 per 1,00,000  No race or gender prediliction  more than 60% of patients with iNPH had cerebrovascular disease.  In another similar study, more than 75% had Alzheimer disease pathology at the time of shunt surgery. 02-Dec-15 4
  • 5.
    IDIOPATHIC – 50% SECONDARY CAUSES  subarachnoid hemorrhage (23%),  meningitis (4.5%)  and traumatic brain injury (12.5%) Secondary NPH has higher response rate to shunting than idiopathic NPH 02-Dec-15 5
  • 6.
     50% casesidiopathic  Leading theory is impairment of CSF outflow  Intraventricular pressure studies reveal waves of increased pressure- B-waves  Adult hydrocephalus syndrome  Adult symptomatic hydrocephalus 02-Dec-15 6
  • 7.
  • 8.
    Ventricle enlargement leadsto periventricular ischemia regardless of etiology Compression and stretching of arterioles and venules Arterial hypertension and cerebral arteriosclerosis increased in NPH 02-Dec-15 8
  • 9.
    Increased subarachnoid spacevolume does not accompany increased ventricular volume. Symptoms result from distortion of the central portion of the corona radiata by the distended ventricles. Interstitial edema of the white matter The periventricular white matter anatomically includes the sacral motor -abnormal gait and incontinence. Dementia results from distortion of the periventricular limbic system.02-Dec-15 9
  • 10.
    Kiefer, M; Unterberg,A The Differential Diagnosis and Treatment of Normal-Pressure Hydrocephalus Dtsch Arztebl Int 2012; 109(1-2): 15-26; DOI: 10.3238/arztebl.2012.0015 02-Dec-15 10
  • 11.
    CLASSIC TRIAD  GAITDISTURBANCE -is typically the earliest feature noted and considered to be the most responsive to treatment  No classic gait disturbance  Gait may be wide based, shuffling  More severely affected patients have “magnetic gait”- feet stuck to ground and difficult to initiate walking  Difficulties with walking motions resolve with minimal support of patient or lying patient down  May resemble Parkinson’s gait  Hyperreflexia  Apraxia of gait – no weakness or ataxia. 02-Dec-15 11
  • 12.
  • 13.
    Urinary Incontinence  Trueincontinence found only in severely affected patients  Urinary urgency in most patients with NPH  Due to stretching of periventricular nerve fibers and loss of detrusor inhibition  Bladder sphincter muscle unaffected 02-Dec-15 13
  • 14.
    DEMENTIA  Usually mild Presence of dementia in NPH extremely variable  Some shunt responsive patients have little or no dementia  Dementia usually least responsive of symptoms to intervention  Mental status changes may resemble depression  prominent memory loss and bradyphrenia.  Frontal and subcortical deficits  forgetfulness, decreased attention,  Aphasia /agnosia – alternate diagnosis -Alzheimer 02-Dec-15 14
  • 15.
     Both ADand NPH cause memory impairment  AD- “cortical” abnormalities  Aphasia, Apraxia, Agnosia  Impaired recognition and encoding deficits  NPH- “subcortical” abnormalities  Memory impairment but intact recognition  Slow information processing  Difficulty with complex tasks 02-Dec-15 15
  • 16.
    AD NPH Impaired Memory Learning Orientation Attention/concentration Executive function Writing Psychomotorslowing Fine motor speed Fine motor accuracy Borderline Impaired Motor and psychomotor skills Visuospatial skills Language Reading Auditory memory Attention/concentration Executive function Behavior/personality changes 02-Dec-15 16
  • 17.
     AD andNPH can usually be distinguished with formal neuropsychological testing  Primary care office testing may not be adequate to distinguish  Mental impairment early in course of AD but usually late in course of NPH and often minimal impairment  AD often associated with hippocampal atrophy on imaging studies 02-Dec-15 17
  • 18.
     Both NPHand Parkinson’s Disease (PD) can have similar gait disturbances  Hypokinesia  Freezing  Imbalance  Extrapyramidal symptoms  Trial of levadopa can help distinguish between PD and NPH 02-Dec-15 18
  • 19.
     Depression  Subcorticalarteriosclerotic encephalopathy  Multi-infarct encephalopathy  Chronic alcoholism  B12, Folate deficiency  Electrolyte abnormalities  Cervical or lumbar stenosis  Peripheral neuropathy 02-Dec-15 19
  • 20.
     History  Insidiousonset  Age over 40  Symptom duration 3-6 months  No antecedent event known to cause secondary NPH  Progressive over time  No other medical, psychiatric or neurological condition that could cause symptoms 02-Dec-15 20
  • 21.
     Brain imaging Ventricular enlargement not attributable to cerebral atrophy or congenital disorder  No macroscopic obstruction present  At least one of the following  Enlargement of lateral horns not attributable to hippocampus atrophy  Callosal angle greater or equal to 40 degrees  Evidence of altered brain water content on imaging not attributable ischemia or demylination  An aqueductal or fourth ventricular flow void on MRI 02-Dec-15 21
  • 22.
  • 23.
     Angle ofroof of lateral ventricles in A-P projection 02-Dec-15 23
  • 24.
     Loss ofMRI signal due to flow of CSF Normal aqueduct Abnormal aqueduct 02-Dec-15 24
  • 25.
    Normal fourth ventricleAbnormal fourth ventricle 02-Dec-15 25
  • 26.
     Clinical  Gait/Balance-at least two of following present  Decreased step height  Decreased step length  Decreased cadence/speed  Decreased trunk sway  Widened stance  Toes turned outward while walking  En bloc turning- turns take three or more steps  Impaired balance- two or more corrective steps for eight steps on tandem gait testing 02-Dec-15 26
  • 27.
     Cognition- twoof following present  Psychomotor slowing  Decreased fine motor speed  Decreased fine motor accuracy  Difficulty dividing or maintaining attention  Impaired recall especially for recent events  Impairment of executive functions- multi-step procedures, working memory, formulation of abstractions, insight  Behavioral or personality changes 02-Dec-15 27
  • 28.
     Urinary Symptoms-one of following  Episodic urinary incontinence not attributable to other causes  Persistent urinary incontinence  Fecal and urinary incontinence OR  One of following  Urinary urgency  Urinary frequency- 6 or more voids in 12 hour period  Nocturia- more than two voids in night 02-Dec-15 28
  • 29.
     Physiological  Openingpressure 70-240 mmH2O 02-Dec-15 29
  • 30.
     History- Symptomsare  Subacute or indeterminate onset  Onset any time after childhood  <3 months or indeterminate duration  May follow trauma, hemorrhage or meningitis  Symptoms not entirely explained by co-existing neurological conditions  Non-progressive or not clearly progressive 02-Dec-15 30
  • 31.
     Brain imaging-Ventricular enlargement associated with following  Cerebral atrophy of sufficient severity to explain ventricular enlargement  Structural lesion that may increase ventricular size 02-Dec-15 31
  • 32.
     Clinical  Incontinenceand/or cognitive impairment in absence of gait or balance dysfunction  Gait disturbance or dementia alone  Physiological  Opening pressure unavailable or outside of range for probable NPH 02-Dec-15 32
  • 33.
    No ventriculomegaly Signs ofincreased intracranial pressure such as papilledema No component of clinical triad Symptoms explained by other causes (eg, spinal stenosis) 02-Dec-15 33
  • 34.
    - Vit B12, Thyroid profile - CSF – analysis – opening pressure – 11 +/- 3 mm hg (150 mm H2o) slightly higher than normal - Transient high pressure B waves may be detected - (CSF) protein Lipocalin-type prostaglandin D synthase (L-PGDS) – marker of Frontal lobe dysfunction in iNPH – decreased due to damage of arachnoid cells 02-Dec-15 34
  • 35.
     Ventriculomegaly thatis out of proportion to sulcal atrophy.  differentiates NPH from ex vacuo ventriculomegaly,  Frontal and occipital periventricular hypoattenuating areas, represent transependymal CSF flow -infrequent and often may represent periventricular leukoencephalopathy  corpus callosal thinning, -nonspecific 02-Dec-15 35
  • 36.
     Rounding offrontal horns  clinical picture and ventriculosulcal disproportion on either CT or MRI scans, 50-70% of patients are likely to respond to a CSF-shunting procedure. 02-Dec-15 36
  • 37.
    disproportionately enlarged temporal hornsof the lateral ventricles compared with the relatively normal sulcal size. 02-Dec-15 37
  • 38.
    The Evans index(EI), a linear ratio between the maximal frontal horn width and the cranium diameter, signifies ventriculomegaly if it is 0.3 02-Dec-15 38
  • 39.
     Temporal hornsout of proportion to hippocampal atrophy  MRI provides additional physiologic information on NPH  T2-weighted images, regions of moving CSF demonstrate no signal, instead of the increased signal observed in slow-moving CSF,  CSF flow studies- jet of turbulent CSF flow may be observed distal to the aqueduct  Cine phase-contrast MRI quantifies CSF flow in terms of stroke volume  - significant corelation to shunt responsiveness02-Dec-15 39
  • 40.
  • 41.
     Most prefer45 -50 ml removal  Csf pressures may be transiently elevated  Improvement may be delayed and appear 1-2 days after  Sensitivity of test – 62 % and 33 % specificity  However it has been listed in guidelines of prognostic evaluation of NPH 02-Dec-15 41
  • 42.
     greater impacton brain volume expansion  300 ml drained for 5 days  Complications -including headache, radiculopathy, and bacterial meningitis  More sensitive than csf tap test  sensitivity, specificity, and negative predictive value were 95%, 64%, and 78%, respectively.  PPV 80 -100 %  Requires hospitalisation specialised care 02-Dec-15 42
  • 43.
  • 44.
     CSF infusiontesting.- One drain is used for continuous pressure monitoring while the other drain is used to continuously infuse solution into the CSF space.  Ro – impedance of flow offered by csf absorption  Isotopic cisternography is no longer in frequent use  Acqueductal CSF flow – not of much diagnostic use 02-Dec-15 44
  • 45.
  • 46.
     Neuropsychological evaluation(eg, Folstein test or formal neuropsychological evaluation)- not validated  Timed walking test.  Videotaping the gait evaluation before and after the large volume lumbar puncture.- IS PREFERABLE  Reduction in bladder hyperactivity also may be a sign of good outcome from shunting. 02-Dec-15 46
  • 47.
     No prospective,double blind, randomized, controlled clinical triaL  Medical management – levodopa trial to rule out idiopthic parkinson disease  No drug is known to work in NPH  Surgical Management – mainstay  Benefit expected from shunt surgery in probable case of NPH 50 %- 61 % 02-Dec-15 47
  • 48.
  • 49.
  • 50.
  • 51.
     Adjustable shuntvalves – adjusts the opening pressure  Gravity-controlled valves - low valve opening pressure when the patient is lying down.  G valves lower the risk of overdrainage by 90% 02-Dec-15 51
  • 52.
     Endoscopic thirdventriculostomy (ETV).  Alternative to shunt placement for treatment of hydrocephalus.  Effective in obstructive hydrocephalus. Efficacy in NPH not known 02-Dec-15 52
  • 53.
     Routine followup 2 to 3 times per year  Earlier if shunt inection/failure  Bedside clinical examination follow up CTScan within few weeks  D Dimer ,CRP in case of ventriculoatrial shunts for subclinical septicemia and thromboembolism 02-Dec-15 53
  • 54.
     High CSFpressure should prompt investigation for a secondary cause of NPH  Response to a 40-mL to 50-mL (high-volume) lumbar tap suggests a potential benefit to shunting  An ELD may be used to evaluate those who do not respond to a high-volume tap  There is no substantial predictive value to MRI CSF flow studies  IF multi-infarct or Alzheimer’s disease dementia ?? 02-Dec-15 54
  • 55.
     Ventricle enlargementon CT or MRI  Severity graded by ratio of maximal frontal horn width divided by transverse inner diameter of skull  0.32 minimal for NPH but 0.40 more typical  Lack of hippocampus or cortical atrophy  Periventricular and cortical white matter lesions may be found in patients with NPH  Large number white matter lesions may be marker for poor response to shunting 02-Dec-15 55
  • 56.
  • 57.
  • 58.
  • 59.
     Most studiesshow fairly significant decline in benefits over time  Initial improvement 60-75% of patients  Sustained improvement only 24-42%  Results confounded due to high mortality from co-morbid conditions  57% patients dead within 5 years in study by Raftopoulos et.al. 02-Dec-15 59
  • 60.
     Good responseto shunting  Clinical presentation  Gait disturbance preceded mental impairment  Short duration of mild mental impairment  Known cause of NPH- e.g. infection, bleed 02-Dec-15 60
  • 61.
     Good responseto shunting  Special studies  Lack of white matter lesions on MRI  Marked resolution of symptoms with CSF drainage  One time removal 30-50 cc CSF  Multi-day drainage of 100-150 cc CSF  B-waves greater than 50% of time with continuous intracranial pressure (ICP) monitoring  Resistance to CSF outflow greater than 18 mmHg 02-Dec-15 61
  • 62.
     Poor responseto shunting  Severe dementia  Dementia presenting symptom  MRI abnormalities  Cerebral atrophy  Multiple white matter lesions 02-Dec-15 62
  • 63.
     Indeterminate significance Patient age  Duration of symptoms  Lack of response to removal CSF 02-Dec-15 63
  • 64.
    Normal pressure hydrocephalus:an update, Stein, SC, Neurosurgery Quarterly (2001)11(1):26–35 02-Dec-15 64
  • 65.
    Normal pressure hydrocephalus:an update, Stein, SC, Neurosurgery Quarterly (2001)11(1):26–35 02-Dec-15 65
  • 66.
     Externally programmablevalve allows transcutaneous adjustment CSF outflow resistance 02-Dec-15 66
  • 67.
  • 68.
     Monitoring ofmental function  Patients should have neuropsychiatric testing prior to shunt  Periodic testing post shunt to document improvement 02-Dec-15 68
  • 69.
     Monitor forcomplications of shunt  Infection  Shunt malfunction  Excessive CSF drainage  Subdural hematoma 02-Dec-15 69
  • 70.
  • 71.
     The INPHis a syndrome, characterized by gait impairment, cognitive decline and urinary incontinence  Associated with ventriculomegaly in the absence of elevated CSF pressure.  Pathogenesis is not understood; intermittent intracranial hypertension, decreased CSF absorption and cerebral ischemia have been blamed.  Hallmark of neuroimaging in NPH is ventriculomegaly out of proportion with sulcal atrophy 02-Dec-15 71
  • 72.
     MRI isthe choice of imaging; CSF flow in NPH is hyperdynamic, with an increase in the amount and velocity of CSF passing rostrally, then caudally, through the cerebral aqueduct with each cardiac cycle.  Clinical improvement after CSF drainage implies good response to shunting.·  The best results are found in the subjects treated with low-pressure valves.·  Increased use of adjustable valve seems to be beneficial.  Gait is most likely to improve. Postoperative reduction in ventriculomegaly is not always seen or proportionate to the clinical improvement. 02-Dec-15 72
  • 73.